[
  {
    "ts": null,
    "headline": "SCHD: Buy The Dip And Call It A Day",
    "summary": "Schwab U.S. Dividend Equity ETF offers a stable 4.1% dividend yield and a low Beta score of 0.625. Find out why SCHD is rated a strong buy.",
    "url": "https://finnhub.io/api/news?id=13272786b5cf39a2952eeac24d9c7c9ed50c4aab48f2d583a3ca95e3305e631f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743843660,
      "headline": "SCHD: Buy The Dip And Call It A Day",
      "id": 133725667,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/184860418/image_184860418.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Schwab U.S. Dividend Equity ETF offers a stable 4.1% dividend yield and a low Beta score of 0.625. Find out why SCHD is rated a strong buy.",
      "url": "https://finnhub.io/api/news?id=13272786b5cf39a2952eeac24d9c7c9ed50c4aab48f2d583a3ca95e3305e631f"
    }
  },
  {
    "ts": null,
    "headline": "Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout",
    "summary": "Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout",
    "url": "https://finnhub.io/api/news?id=5819a095f5ce7ff62af0002f01ef824941e9b6f627ef88cbc30cd37e023de276",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743840853,
      "headline": "Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout",
      "id": 133725543,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5819a095f5ce7ff62af0002f01ef824941e9b6f627ef88cbc30cd37e023de276"
    }
  }
]